Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Terns Pharmaceuticals, Inc. per 2025 Jun 30 adalah -105.70 MM.
- Nilai net income untuk Terns Pharmaceuticals, Inc. per 2025 Jun 30 adalah -91.75 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -105.70 | -91.75 | |
2025-03-31 | -103.85 | -90.39 | |
2024-12-31 | -101.87 | -88.85 | |
2024-09-30 | -99.98 | -88.07 | |
2024-06-30 | -108.22 | -95.89 | |
2024-03-31 | -103.85 | -91.06 | |
2023-12-31 | -102.56 | -90.21 | |
2023-09-30 | -95.33 | -85.01 | |
2023-06-30 | -79.44 | -72.07 | |
2023-03-31 | -72.36 | -68.10 | |
2022-12-31 | -62.03 | -60.34 | |
2022-09-30 | 1.00 | -59.08 | -58.77 |
2022-06-30 | 1.00 | -53.66 | -53.79 |
2022-03-31 | 1.00 | -50.39 | -50.59 |
2021-12-31 | 1.00 | -49.86 | -50.16 |
2021-09-30 | -44.75 | -35.14 | |
2021-06-30 | -41.62 | -34.74 | |
2021-03-31 | -40.90 | -33.69 | |
2020-12-31 | -37.02 | -29.35 | |
2020-09-30 | -3.20 | -39.90 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -1.18 | -1.18 |
2024-06-30 | -1.31 | -1.31 |
2024-03-31 | -1.26 | -1.26 |
2023-12-31 | -1.27 | |
2023-09-30 | -1.27 | -1.27 |
2023-06-30 | -1.23 | -1.23 |
2023-03-31 | -1.44 | -1.44 |
2022-12-31 | -1.67 | |
2022-09-30 | -2.05 | -2.05 |
2022-06-30 | -2.13 | -2.13 |
2022-03-31 | -2.01 | -2.01 |
2021-12-31 | -2.21 | |
2021-09-30 | -2.13 | -2.13 |
2021-06-30 | -3.39 | -3.39 |
2021-03-31 | -8.38 | -8.38 |
2020-12-31 | -102.93 | |
2020-09-30 | -155.30 | -155.30 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Terns Pharmaceuticals, Inc. per 2025 Jun 30 adalah -74.36 MM.
- Nilai cash from investing activities untuk Terns Pharmaceuticals, Inc. per 2025 Jun 30 adalah -35.14 MM.
- Nilai kas dari aktivitas pendanaan untuk Terns Pharmaceuticals, Inc. per 2025 Jun 30 adalah 163.99 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -74.36 | -35.14 | 163.99 |
2025-03-31 | -71.66 | -18.45 | 164.06 |
2024-12-31 | -70.02 | -12.41 | 164.00 |
2024-09-30 | -74.75 | 129.17 | 177.55 |
2024-06-30 | -78.99 | 75.11 | 14.28 |
2024-03-31 | -75.81 | -57.92 | 14.37 |
2023-12-31 | -67.39 | -37.99 | 41.95 |
2023-09-30 | -59.28 | -99.77 | 134.06 |
2023-06-30 | -52.02 | -78.69 | 195.04 |
2023-03-31 | -50.19 | -3.83 | 194.68 |
2022-12-31 | -49.11 | -22.27 | 167.09 |
2022-09-30 | -48.57 | -14.15 | 61.14 |
2022-06-30 | -43.21 | -8.46 | 0.94 |
2022-03-31 | -40.81 | -13.39 | -0.78 |
2021-12-31 | -41.83 | -119.70 | 134.39 |
2021-09-30 | -38.55 | -113.32 | 203.02 |
2021-06-30 | -36.78 | -117.77 | 202.25 |
2021-03-31 | -36.84 | -96.97 | 220.72 |
2020-12-31 | -29.81 | 6.69 | 85.52 |
2020-09-30 | -31.95 | 10.81 | 16.85 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -3.60.
- p/libro untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 1.00.
- p/tbv untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 1.00.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -3.60 | 1.00 | 1.00 |
2025-03-31 | 0.74 | 0.74 | |
2024-12-31 | 1.29 | 1.29 | |
2024-09-30 | -7.53 | 3.30 | 3.30 |
2024-06-30 | -5.05 | 1.94 | 1.94 |
2024-03-31 | -4.41 | 1.56 | 1.56 |
2023-12-31 | -4.72 | 1.55 | 1.55 |
2023-09-30 | -3.98 | 1.05 | 1.05 |
2023-06-30 | -7.05 | 1.67 | 1.67 |
2023-03-31 | -11.14 | 2.43 | |
2022-12-31 | 2.73 | 2.73 | |
2022-09-30 | 1.61 | 1.61 | |
2022-06-30 | -1.22 | 0.42 | 0.42 |
2022-03-31 | -1.49 | 0.43 | 0.43 |
2021-12-31 | -5.05 | 1.03 | 1.03 |
2021-09-30 | -7.56 | 1.45 | 1.45 |
2021-06-30 | |||
2021-03-31 | -1.12 | 0.55 | 0.55 |
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.48.
- EBIT (3 tahun) / EV untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.46.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.48 | -0.46 |
2025-03-31 | -0.95 | -0.88 |
2024-12-31 | -0.44 | -0.40 |
2024-09-30 | -0.15 | -0.13 |
2024-06-30 | -0.23 | -0.18 |
2024-03-31 | -0.28 | -0.21 |
2023-12-31 | -0.23 | -0.16 |
2023-09-30 | -0.35 | -0.26 |
2023-06-30 | -0.23 | -0.17 |
2023-03-31 | -0.11 | -0.09 |
2022-12-31 | -0.13 | -0.10 |
2022-09-30 | -0.26 | -0.21 |
2022-06-30 | -2.78 | -2.82 |
2022-03-31 | -1.85 | -1.88 |
2021-12-31 | -0.31 | -0.39 |
2021-09-30 | -0.17 | -0.13 |
2021-06-30 | ||
2021-03-31 | -0.22 | -0.26 |
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.39.
- roe untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.41.
- roic untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.28.
- croic untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 0.23.
- ocroic untuk Terns Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.22.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.39 | -0.41 | -0.28 | 0.23 | -0.22 |
2025-03-31 | -0.36 | -0.38 | -0.26 | 0.23 | -0.20 |
2024-12-31 | -0.33 | -0.34 | -0.24 | 0.63 | -0.20 |
2024-09-30 | -0.35 | -0.37 | -0.44 | 0.05 | -0.36 |
2024-06-30 | -0.30 | -0.32 | -0.38 | -0.50 | -0.32 |
2024-03-31 | -0.31 | -0.33 | -0.35 | -0.25 | -0.26 |
2023-12-31 | -0.44 | -0.46 | -0.33 | -0.10 | -0.23 |
2023-09-30 | -0.50 | -0.53 | -0.26 | 0.23 | -0.19 |
2023-06-30 | -0.47 | -0.50 | -0.26 | 0.23 | -0.19 |
2023-03-31 | -0.39 | -0.41 | -0.24 | 0.49 | -0.17 |
2022-12-31 | -0.33 | -0.34 | -0.32 | -0.01 | -0.26 |
2022-09-30 | -0.30 | -0.31 | -0.32 | -0.01 | -0.26 |
2022-06-30 | -0.27 | -0.28 | -0.39 | -0.37 | -0.31 |
2022-03-31 | -0.25 | -0.73 | -0.34 | -0.37 | -0.27 |
2021-12-31 | -0.38 | -0.51 | -0.29 | -0.16 | -0.22 |
2021-09-30 | -1.99 | -0.20 | 0.30 | -0.20 | |
2021-06-30 | -1.45 | -1.90 | -0.18 | 0.25 | -0.19 |
2021-03-31 | -1.41 | -1.84 | -0.17 | 0.43 | -0.45 |
2020-12-31 | -1.23 | -1.60 | -0.36 | 0.77 | -0.37 |
2020-09-30 | -4.93 | -0.46 | -3.95 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | 1.00 | -58.77 | -59.08 |
2022-09-30 | 1.00 | -58.77 | -59.08 |
2022-06-30 | 1.00 | -53.79 | -53.66 |
2022-03-31 | 1.00 | -50.59 | -50.39 |
2021-12-31 | -50.16 | -49.86 | |
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1831363 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |